ライフサイエンスコーパス: multiparametric MRI

1 edictive value and specificity when added to multiparametric MRI.

2 ic ultrasound is more readily available than multiparametric MRI.

3 nderwent both multiparametric ultrasound and multiparametric MRI.

4 d pre-operative grading of meningiomas using multiparametric MRI.

5 sions, and normal-appearing brain tissues on multiparametric MRI.

6 zed management of breast cancer patients via multiparametric MRI.

7 ion of primary prostate cancer compared with multiparametric MRI.

8 on, especially when used in combination with multiparametric MRI.

9 (18)F-DCFPyL PET/CT imaging and 3.0-T pelvic multiparametric MRI.

10 localization, especially when combined with multiparametric MRI.

11 cancer with hybrid multidimensional MRI than multiparametric MRI.

12 ith even greater accuracy when combined with multiparametric MRI.

13 IFU, the patients underwent prostate biopsy, multiparametric MRI, (68)Ga-PSMA11, and (68)Ga-RM2 PET/M

14 city was higher for (68)Ga-PSMA PET/MRI than multiparametric MRI (76% [95% CI: 62, 86] vs 49% [95% CI

15 also higher for (68)Ga-PSMA PET/MRI than for multiparametric MRI: 86% (95% CI: 73, 95) versus 59% (95

16 total of 310 consecutive patients underwent multiparametric MRI according to a standardized institut

17 7 (20% [12-31]) were exclusively detected by multiparametric MRI (agreement 91.1% [95% CI 86.9-94.2];

18 Today, advances in multiparametric MRI allow for detection and targeted bio

19 gnostic accuracy and interrater agreement of multiparametric MRI and (68)Ga-PSMA-11 PET/MRI for the d

20 analysis of 40 consecutive men who underwent multiparametric MRI and (68)Ga-PSMA-11 PET/MRI within 6

21 ompleted both multiparametric ultrasound and multiparametric MRI and 257 underwent a prostate biopsy.

22 Prostate multiparametric MRI and both cardiac and pelvic (15)O-H(

23 cancer (csPCa; Gleason score 3+4) combining multiparametric MRI and clinical factors have demonstrat

24 primary care) with multiorgan, quantitative, multiparametric MRI and compared with 134 matched contro

25 It was found that a combination of multiparametric MRI and gene expression data allowed the

26 rostate cancer, and who could safely undergo multiparametric MRI and have a general anaesthetic.

27 atic biopsy and sampling labeling along with multiparametric MRI and magnetic resonance-targeted biop

28 Purpose To compare multiparametric MRI and micro-US in detecting csPCa (gra

29 ected or known prostate cancer who underwent multiparametric MRI and MRI/US-guided biopsy from April

30 positive lesions on, and agreement between, multiparametric MRI and multiparametric ultrasound in id

31 We then discuss the utility of prebiopsy multiparametric MRI and novel tumour markers.

32 tandardized uptake values were compared with multiparametric MRI and pathology.

33 tz and colleagues, the authors have combined multiparametric MRI and PET imaging to address the impor

34 ment of patients with high-grade glioma, but multiparametric MRI and PET tracers could provide furthe

35 ings rated the probability of ECE and SVI at multiparametric MRI and PET/MRI by using a five-point Li

36 nd accuracy were determined for conventional multiparametric MRI and quantitative DWI-derived data.

37 Multiparametric MRI and targeted and systematic biopsies

38 (IIEF-15) score at 6 weeks and 5 months, and multiparametric MRI and targeted biopsy of the treated a

39 ng, advances in imaging technologies such as multiparametric MRI, and the identification of serum-, t

40 stic modalities such as serum PSA levels and multiparametric MRI, and the optimal management for loca

41 study, with a cohort of 13 patients with CT, multiparametric MRI, and tumor biopsies.

42 sease course in MS by using a comprehensive, multiparametric MRI approach.

43 the authors, not been investigated by using multiparametric MRI approaches.

44 rent imaging modalities, only ultrasound and multiparametric MRI are intimately involved in the detec

45 metric ultrasound could be an alternative to multiparametric MRI as a first test for patients at risk

46 95% CI 83-99) had no evidence of disease on multiparametric MRI at 12 months.

47 uded 163 patients with stage I-III TNBC with multiparametric MRI at baseline and after 2 (C2) and 4 c

48 The advanced multiparametric MRI-based glioma score can predict the I

49 Our data supports multiparametric MRI-based radiomic models for early pred

50 st 2020 to assess the diagnostic accuracy of multiparametric MRI before biopsy in detection of csPCa

51 ctive case-control study, patients underwent multiparametric MRI before MRI-guided biopsy followed by

52 lvic (11)C-acetate PET/CT for 30 min and 3-T multiparametric MRI before prostatectomy.

53 s Men with histologically proven DAC who had multiparametric MRI before radical prostatectomy were re

54 roximate volume enhancement) SRMs undergoing multiparametric MRI between December 2012 and December 2

55 tional study included patients who underwent multiparametric MRI between September 2016 and May 2021

56 role of transperineal template biopsies and multiparametric MRI, both for patient selection and in i

57 is to classify ccRCC noninvasively by using multiparametric MRI, but it lacks external validation.

58 clinically significant prostate cancers than multiparametric MRI, but it would lead to 11.1% more pat

59 2) were compared for (68)Ga-PSMA PET/MRI and multiparametric MRI by using the McNemar test.

60 Multiparametric MRI can be used to direct prostate biops

61 Background Multiparametric MRI can help identify clinically signifi

62 at risk of prostate cancer, particularly if multiparametric MRI cannot be carried out.

63 We propose the use of patient-specific multiparametric MRI consisting of Dixon MRI and proton-d

64 Purpose To develop multiparametric MRI criteria to define DAC and to assess

65 ging Reporting and Data System (PI-RADS) for multiparametric MRI data acquisition, interpretation, an

66 In this study, we proposed to use a multiparametric MRI data as a sequence input for the con

67 esults demonstrate the plausibility of using multiparametric MRI data to inform spatially-informative

68 21-32]) of 257 patients who had biopsies and multiparametric MRI detecting it in 77 (30% [24-36]; dif

69 nique improves the diagnostic performance of multiparametric MRI examinations of the prostate.

70 tudy, consecutive participants who underwent multiparametric MRI followed by a combined biopsy, inclu

71 All patients underwent multiparametric MRI followed by micro-US; findings at bo

72 and specificity of (68)Ga-PSMA PET/MRI with multiparametric MRI for detecting CSPC.

73 software for improving the image quality of multiparametric MRI for gliomas in a multinational setti

74 e design, conduct, and results of the Breast Multiparametric MRI for prediction of neoadjuvant chemot

75 qualitatively with heterogeneity observed in multiparametric MRI habitats and histology.

76 n The clear cell likelihood score applied to multiparametric MRI had moderate interobserver agreement

77 Multiparametric MRI has been shown to be imperative to r

78 Background Multiparametric MRI has led to increased detection of cl

79 Multiparametric MRI helped correctly identify 131 of 182

80 al imaging (bone scan and CT with or without multiparametric MRI) helped to detect more nodal and dis

81 (hereafter referred to as PSMA), and pelvic multiparametric MRI (hereafter referred to as pelvic MRI

82 (PET) with bone scan and CT with or without multiparametric MRI (hereafter, referred to as conventio

83 mprove detection of recurrence compared with multiparametric MRI; however, histopathologic validation

84 Multiparametric MRI identified 18 lesions; 14 of them we

85 The addition of (18)F-DCFPyL to multiparametric MRI improved PPV by 38% overall (P = .02

86 s the diagnostic performance of conventional multiparametric MRI in all O-RADS MRI score groups.

87 all, there is consensus on the importance of multiparametric MRI in diagnosis and staging prior to ac

88 stologic analysis and to compare with pelvic multiparametric MRI in men with biochemically recurrent

89 The focus of this study is to review multiparametric MRI in the detection and risk stratifica

90 assess the diagnostic accuracy of prebiopsy multiparametric MRI in the identification of clinically

91 for (18)F-Fluciclovine PET and multisequence multiparametric MRI in the prediction of prostate cancer

92 Multiparametric MRI included high-resolution T2-weighted

93 /- 9 [standard deviation], 18 men) underwent multiparametric MRI, including IVIM DWI and gadoxetic ac

94 odality-experts model (MOME) that integrates multiparametric MRI information within a unified structu

95 This work demonstrates that multiparametric MRI is a powerful tool for the assessmen

96 Multiparametric MRI is a useful tool in the initial asse

97 To date, multiparametric MRI is the most effective imaging techni

98 Multiparametric MRI is the most established form of imag

99 y is ideal for diagnosis, particularly where multiparametric MRI is unavailable.

100 ar cell likelihood score (ccLS) derived from multiparametric MRI is useful in noninvasively identifyi

101 difference in upgrade rates as a function of multiparametric MRI lesion size (P = .53-.59) or locatio

102 3 + 4; clinical stage, <=T2c; lesion size at multiparametric MRI, <=20 mm) underwent focal MRI/transr

103 82 participants who were eligible to undergo multiparametric MRI (mean age, 65 years +/- 6 [SD]).

104 th suspected prostate cancer (PCa) underwent multiparametric MRI (mp-MRI) and VERDICT-MRI followed by

105 ent tumor masks, comparison of single versus multiparametric MRI (mp-MRI) or select combination of se

106 PET findings were compared with preoperative multiparametric MRI (mpMRI) (n = 36) and (68)Ga-PSMA11 P

107 score in a cohort of patients who underwent multiparametric MRI (mpMRI) and (68)Ga-PSMA PET before p

108 Multiparametric MRI (mpMRI) and prostate-specific membra

109 taging of local disease by comparing it with multiparametric MRI (mpMRI) and radical prostatectomy (R

110 onalized precision medicine, the accuracy of multiparametric MRI (mpMRI) and targeted biopsy in helpi

111 portant imaging modalities in focal therapy, multiparametric MRI (mpMRI) and ultrasonography.

112 Performance was compared with that of multiparametric MRI (mpMRI) assessed per Prostate Imagin

113 have been shown to help this process, using multiparametric MRI (mpMRI) data to detect PCa, effectiv

114 ng and Reporting Data System (PI-RADS)-based multiparametric MRI (mpMRI) evaluation by expert radiolo

115 cancer (PCa), up to 50% of men with positive multiparametric MRI (mpMRI) findings (Prostate Imaging R

116 8)Ga]Ga-PSMA-11 PET, [(68)Ga]Ga-RM2 PET, and multiparametric MRI (mpMRI) for the detection of primary

117 Targeting of lesions seen on multiparametric MRI (mpMRI) improves prostate cancer (PC

118 Background Multiparametric MRI (mpMRI) improves prostate cancer (PC

119 antigen (PSMA)-targeted PET in comparison to multiparametric MRI (mpMRI) in the evaluation of intrapr

120 treatment of prostate cancer do not consider multiparametric MRI (mpMRI) information.

121 Multiparametric MRI (mpMRI) is currently used for tumor

122 Background Multiparametric MRI (mpMRI) is effective for detecting p

123 Multiparametric MRI (mpMRI) is validated for the diagnos

124 Thus, we investigated multiparametric MRI (mpMRI) metrics of liver fat (proton

125 Multiparametric MRI (mpMRI) of the prostate has been ide

126 ucagon improves T2-weighted image quality at multiparametric MRI (mpMRI) of the prostate.

127 Purpose To determine which quantitative 3-T multiparametric MRI (mpMRI) parameters correlate with an

128 f acquisition and interpretation of prostate multiparametric MRI (mpMRI) persists despite implementat

129 (FN) results for prostate cancer at prostate multiparametric MRI (mpMRI) using the Prostate Imaging a

130 the cost-effectiveness of (18)F-choline PET/multiparametric MRI (mpMRI) versus mpMRI alone for the d

131 A combination of uPAR PET and multiparametric MRI (mpMRI) was performed, and the SUV i

132 (bpMRI) of the prostate is an alternative to multiparametric MRI (mpMRI), with lower cost and increas

133 mpare the detection of Cr/IDC-pattern PCa at multiparametric MRI (mpMRI)-targeted biopsy versus syste

134 end reimaging with (68)Ga-PSMA-11 PET/CT and multiparametric MRI (mpMRI).

135 C response to neoadjuvant immunotherapy with multiparametric MRI (mpMRI).

136 of patients is recommended with biopsies and multiparametric MRI (mpMRI).

137 scular-anatomical maps can be generated from multiparametric MRI/MRA.

138 dual patients will most likely result from a multiparametric (MRI/MRSI/DTI/DCE) exam using 3T magneti

139 Multiparametric MRI of the bladder is highly accurate in

140 precision laser ablation, patients underwent multiparametric MRI of the prostate at 48 to 72 h, follo

141 Multiparametric MRI of the prostate followed by targeted

142 Multiparametric MRI of the prostate gland is a relativel

143 Multiparametric MRI of the prostate is now recommended a

144 d Data System (PI-RADS) version 2.0 requires multiparametric MRI of the prostate, including diffusion

145 ricted diffusion and contrast enhancement at multiparametric MRI of the prostate, suggests prostatic

146 onal neural network (CNN) was trained on the multiparametric MRIs of the discovery set to classify ea

147 to PSMA uptake increased the net benefit of multiparametric MRI only among PI-RADS 3 lesions.

148 ve planning with prostate biopsy results and multiparametric MRI only or to an intervention group in

149 %), and 66% (19 of 29; 95% CI: 44%, 86%) for multiparametric MRI (P = .19, P = .02, and P = .17, resp

150 %), and 69% (24 of 35; 95% CI: 50%, 88%) for multiparametric MRI (P = .95, P = .14, and P = .07, resp

151 ly significant prostate cancer compared with multiparametric MRI, particularly in Prostate Imaging Re

152 Using a multiparametric MRI-pathologic cross-correlative approac

153 antigen (PSMA) ((68)Ga-PSMA-11) PET/MRI and multiparametric MRI perform similarly for local staging

154 rostate Cancer, Hybrid Multidimensional MRI, Multiparametric MRI, PI-RADS Clinical trial registration

155 col (84.3%; 95% CI: 77.7, 89.2) and the full multiparametric MRI protocol (85.9%; 95% CI: 80.0, 90.3;

156 it may be difficult to detect using current multiparametric MRI protocols.

157 3DCNN) based method, for brain extraction on multiparametric MRI scans (mpMRIs).

158 The network input consisted of 1970 multiparametric MRI scans from 1008 patients recruited f

159 FDG-PET and multiparametric MRI scans were conducted before radiatio

160 These methods may be not optimal for multiparametric MRI scans.

161 ely underwent (68)Ga-PSMA PET/MRI, including multiparametric MRI sequences, between June 2019 and Mar

162 derived from combined (18)F-fluciclovine PET/multiparametric MRI show potential for detection and cha

163 Combined (18)F-fluciclovine PET/multiparametric MRI shows potential for improving detect

164 The area under the curve (AUC) of multiparametric MRI signal to classify lesion age <4.5 h

165 Multiparametric MRI signal was compared with NWU using l

166 Comprehensive, multiparametric MRI studies are useful in this perspecti

167 s from 18 countries submitted a total of 355 multiparametric MRI studies from 71 scanners, with nine

168 lesions in consecutive men who underwent 3-T multiparametric MRI (T2-weighted, DWI, and DCE MRI) from

169 ith a margin of normal tissue, identified on multiparametric MRI, template prostate-mapping biopsies,

170 ement between multiparametric ultrasound and multiparametric MRI to diagnose clinically significant p

171 ve findings on multiparametric ultrasound or multiparametric MRI underwent targeted biopsies but were

172 Interrater reliability for multiparametric MRI versus PET/MRI did not differ for EC

173 Results For multiparametric MRI versus PET/MRI in ECE detection, res

174 For multiparametric MRI versus PET/MRI in SVI detection, res

175 Conclusion Prebiopsy multiparametric MRI was accurate in the depiction of cli

176 Multiparametric MRI was performed on 5 patients, with Pr

177 272 (89% [95% CI 85-92]) of 306 patients and multiparametric MRI was positive in 238 patients (78% [7

178 Multiparametric MRI was used to measure fibro-inflammati

179 The DRs of (18)F-choline PET/CT and multiparametric MRI were 56% and 74%, respectively.

180 and Reporting Data System [PI-RADS] >=3) at multiparametric MRI were first randomized to either syst

181 omised, controlled trials support the use of multiparametric MRI, whereas the evidence for individual

182 nd normal prostate tissue in comparison with multiparametric MRI, whole-mount histopathology, and cli

183 ltiple sclerosis from images from unenhanced multiparametric MRI with moderate to high accuracy.

184 isualized in 77 men by using (18)F-DCFPyL or multiparametric MRI, with imaging detection concordance

185 (64)CuCl2 PET/CT, (18)F-choline PET/CT, and multiparametric MRI within 15 d of each other.